Publicaciones en colaboración con investigadores/as de Centro Nacional de Microbiología (43)

2020

  1. Executive summary: Consensus document of the diagnosis, management and prevention of infection with the hepatitis E virus: Study Group for Viral Hepatitis (GEHEP) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 1, pp. 28-32

2019

  1. Antibody responses to chimeric peptides derived from parasite antigens in mice and other animal species

    Molecular Immunology, Vol. 106, pp. 1-11

  2. In-plate recapturing of a dual-tagged recombinant Fasciola antigen (FhLAP) by a monoclonal antibody (US9) prevents nonspecific binding in ELISA

    PLoS ONE, Vol. 14, Núm. 2

  3. Molecular characterization of salmonella enterica serovar enteritidis, genetic basis of antimicrobial drug resistance and plasmid diversity in ampicillin-resistant isolates

    Microbial Drug Resistance, Vol. 25, Núm. 2, pp. 219-226

2018

  1. Comparison of recombinant cathepsins L1, L2, and L5 as ELISA targets for serodiagnosis of bovine and ovine fascioliasis

    Parasitology Research, Vol. 117, Núm. 5, pp. 1521-1534

  2. Salmonella enterica serovars typhimurium and enteritidis causing mixed infections in febrile children in Mozambique

    Infection and Drug Resistance, Vol. 11, pp. 195-204

2017

  1. Delineating distinct heme-scavenging and -binding functions of domains in MF6p/helminth defense molecule (HDM) proteins from parasitic flatworms

    Journal of Biological Chemistry, Vol. 292, Núm. 21, pp. 8667-8682

  2. Fasciola spp: Mapping of the MF6 epitope and antigenic analysis of the MF6p/HDM family of heme-binding proteins

    PLoS ONE, Vol. 12, Núm. 11

2015

  1. ANISERP: A new serpin from the parasite Anisakis simplex

    Parasites and Vectors, Vol. 8, Núm. 1

2014

  1. Emerging Trichosporon asahii in elderly patients: Epidemiological and molecular analysis by the DiversiLab system

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 33, Núm. 9, pp. 1497-1503

  2. The MF6p/FhHDM-1 major antigen secreted by the trematode parasite fasciola hepatica is a heme-binding protein

    Journal of Biological Chemistry, Vol. 289, Núm. 3, pp. 1441-1456

2013

  1. Prevalence of Shiga toxin-producing Escherichia coli, Salmonella spp. and Campylobacter spp. in large game animals intended for consumption: Relationship with management practices and livestock influence

    Veterinary Microbiology, Vol. 163, Núm. 3-4, pp. 274-281

2012

  1. Ani s 1 and Ani s 7 recombinant allergens are able to differentiate distinct Anisakis simplex-associated allergic clinical disorders

    Archives of Dermatological Research, Vol. 304, Núm. 4, pp. 283-288

2011

  1. Development and evaluation of a new lateral flow immunoassay for serodiagnosis of human fasciolosis

    PLoS Neglected Tropical Diseases, Vol. 5, Núm. 11

  2. Emergence in Spain of a multidrug-resistant Enterobacter cloacae clinical isolate producing SFO-1 extended-spectrum β-lactamase

    Journal of Clinical Microbiology, Vol. 49, Núm. 3, pp. 822-828

  3. MISS-Prot: Web server for self/non-self discrimination of protein residue networks in parasites; Theory and experiments in Fasciola peptides and Anisakis allergens

    Molecular BioSystems, Vol. 7, Núm. 6, pp. 1938-1955

  4. Molecular and immunological characterization of Fasciola antigens recognized by the MM3 monoclonal antibody

    Molecular and Biochemical Parasitology, Vol. 179, Núm. 2, pp. 80-90

  5. Using entropy of drug and protein graphs to predict FDA drug-target network: Theoretic-experimental study of MAO inhibitors and hemoglobin peptides from Fasciola hepatica

    European Journal of Medicinal Chemistry, Vol. 46, Núm. 4, pp. 1074-1094

2010

  1. Detection and characterisation of O157:H7 and non-O157 Shiga toxin-producing Escherichia coli in wild boars

    Veterinary Microbiology, Vol. 143, Núm. 2-4, pp. 420-423

  2. Diagnosing human anisakiasis: Recombinant Ani s 1 and Ani s 7 allergens versus the UniCAP 100 fluorescence enzyme immunoassay

    Clinical and Vaccine Immunology, Vol. 17, Núm. 4, pp. 496-502